FDA advises against Enhancement intranasal splint as dermal filler
Posted on: 06/08/2014 - 18:00
The Food and Drug Administration has issued a warning about adverse events associated with use of the Expression intranasal splint as a dermal filler
Field of Interest: Dermatology
Type: News Item